Ms. Millicker is a Nursing Student, and Dr. Starkweather is Professor and Associate Dean, Center for Advancement in Managing Pain, University of Connecticut School of Nursing, 231 Glenbrook Rd, Storrs, CT 06269; E-mail: [email protected].
The purpose of this article is to review evidence on the use of IV ketamine for prevention and management of chronic pain conditions.
The authors, faculty, and staff in a position to control the content of this CME/CNE activity have disclosed that they and their spouses/life partners (if any) have no financial relationships with, or financial interests in, any commercial organizations relevant to this educational activity.
Lippincott Continuing Medical Education Institute, Inc., is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Lippincott Continuing Medical Education Institute, Inc., designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. To earn CME credit, you must read the CME article and complete the quiz and evaluation assessment survey on the enclosed form, answering at least 70% of the quiz questions correctly. This CME activity expires on October 31, 2022.
Lippincott Professional Development is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. Lippincott Professional Development will award 1.0 contact hours for this continuing nursing education activity. This activity has been assigned 1.0 pharmacology credits. Instructions for earning ANCC contact hours are included on page 11 of the newsletter. This CNE activity expires on September 2, 2022.